Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When should Candida isolates be tested for susceptibility to azole antifungal agents?

× No keyword cloud information.

8 in total

Review 1. Resistance of Candida species to fluconazole.

Authors: J H Rex; M G Rinaldi; M A Pfaller
Journal: Antimicrob Agents Chemother Date: 1995-01 Impact factor: 5.191

Review 2. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.

Authors: J H Rex; M A Pfaller; J N Galgiani; M S Bartlett; A Espinel-Ingroff; M A Ghannoum; M Lancaster; F C Odds; M G Rinaldi; T J Walsh; A L Barry
Journal: Clin Infect Dis Date: 1997-02 Impact factor: 9.079

Review 3. Azole resistance in Candida.

Authors: D W Denning; G G Baily; S V Hood
Journal: Eur J Clin Microbiol Infect Dis Date: 1997-04 Impact factor: 3.267

4. Fluconazole treatment of candidal infections caused by non-albicans Candida species.

Authors: J W van 't Wout
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-03 Impact factor: 3.267

5. Fluconazole disk diffusion procedure for determining susceptibility of Candida species.

Authors: A L Barry; S D Brown
Journal: J Clin Microbiol Date: 1996-09 Impact factor: 5.948

6. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.

Authors: F Lacassin; F Damond; C Chochillon; P Longuet; J Lebras; J L Vilde; C Leport
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

7. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors: J H Rex; M A Pfaller; A L Barry; P W Nelson; C D Webb
Journal: Antimicrob Agents Chemother Date: 1995-01 Impact factor: 5.191

8. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Authors: D Sanglard; K Kuchler; F Ischer; J L Pagani; M Monod; J Bille
Journal: Antimicrob Agents Chemother Date: 1995-11 Impact factor: 5.191

8 in total

6 in total

1. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods.

Authors: E Cantón; J Pemán; A Carrillo-Muñoz; A Orero; P Ubeda; A Viudes; M Gobernado
Journal: J Clin Microbiol Date: 1999-07 Impact factor: 5.948

2. Detection of fluconazole-resistant Candida strains by a disc diffusion screening test.

Authors: P Sandven
Journal: J Clin Microbiol Date: 1999-12 Impact factor: 5.948

3. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.

Authors: A L Barry; M A Pfaller; R P Rennie; P C Fuchs; S D Brown
Journal: Antimicrob Agents Chemother Date: 2002-06 Impact factor: 5.191

4. Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

Authors: S Brown; M Traczewski
Journal: J Clin Microbiol Date: 2006-11-08 Impact factor: 5.948

5. Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.

Authors: A Barry; J Bille; S Brown; D Ellis; J Meis; M Pfaller; R Rennie; M Rinaldi; T Rogers; M Traczewski
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

6. Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp.

Authors: M Carmen Rubio; Joaquina Gil; Inmaculada Ramírez De Ocáriz; Rafael Benito; Antonio Rezusta
Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948

6 in total